MITA takes aim at CMS proposal to limit Alzheimer's drug coverage
The Medical Imaging & Technology Alliance (MITA) is speaking out agains...Read more on AuntMinnie.comRelated Reading: CMS to limit coverage of new drugs for Alzheimer's disease MITA hails radiopharmaceutical legislation MITA comments on '21st Century Cures 2.0' discussion MITA asks for action on third-party servicing firms MITA comments on proposed payment changes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 21, 2022 Category: Radiology Source Type: news

AHN team part of international study on Alzheimer's disease therapy
The ADvance II study is expected to last four years and the study is enrolling potential test subjects. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 21, 2022 Category: Health Management Authors: Paul J. Gough Source Type: news

Can Neonatal Herpes Lead to Alzheimer ’s Disease?
MD/PhD candidate Abigail Dutton is looking for answers—from incurious mice. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - January 21, 2022 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Research Source Type: news

Novel Biomarker Found for Alzheimer's Disease Novel Biomarker Found for Alzheimer's Disease
The rate of cellular amyloid uptake and metabolic production of toxic amyloid species could be used as novel biomarkers for early and/or differential diagnosis of Alzheimer's disease.First Look (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 20, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Sidney Poitier died of heart failure, dementia and prostate cancer, death certificate says
Sidney Poitier, the renowned actor, director and activist, died of a combination of heart failure, Alzheimer’s dementia and prostate cancer, according to his #sidneypoitier #alzheimer #activist (Source: Reuters: Health)
Source: Reuters: Health - January 19, 2022 Category: Consumer Health News Source Type: news

Covid infection can cause debilitating brain condition that causes more damage than Alzheimer's
Researchers at NYU found that some elderly people who were infected with Covid were developing a condition that caused them more brain damage than Alzheimer's does. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2022 Category: Consumer Health News Source Type: news

Concussion Sequelae Boost Alzheimer's Risk Concussion Sequelae Boost Alzheimer's Risk
Post-traumatic amnesia and chronic vascular lesions are risk factors for subsequent Alzheimer's disease following traumatic brain injury, new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 17, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

When Dementia Strikes at an Early Age
Dementia in a person in their 30s, 40s or 50s poses special challenges, starting with getting a diagnosis. (Source: NYT Health)
Source: NYT Health - January 17, 2022 Category: Consumer Health News Authors: Jane E. Brody Tags: Alzheimer ' s Disease Memory Dementia Dreams Chronic Traumatic Encephalopathy Brain Sports Injuries Age, Chronological Frontotemporal Dementia JAMA Neurology (Journal) Source Type: news

Is detecting signs of skin cancer in the bathroom mirror in our future?
The field of medicine is currently experiencing an incredible surge in innovation, driven by groundbreaking new biological discoveries, a digital revolution and a growing willingness to collaborate in research globally. What can patients expect for the future? Will we someday be able to cure cancer? How can we help people who urgently need a donor organ? When will we be able to effectively fight neurodegenerative diseases such as Alzheimer's or Parkinson's? These are some of the major questions… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 17, 2022 Category: American Health Authors: Bayer Source Type: news

Scientists identify malfunctioning brain cells as potential target for Alzheimer's treatment
For the first time, scientists have identified a rare population of potentially toxic senescent cells in human brains that can serve as a target for a new Alzheimer ’s disease treatment. The study, published in the Dec.10 edition of the journal Nature Aging, was led by Miranda Orr, an assistant professor of gerontology and geriatric medicine, at Wake Forest School of Medicine and research health scientist at the W.G. Hefner VA Medical Center, and Habil Zare, an assistant professor of cell systems… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 15, 2022 Category: American Health Authors: Atrium Health Wake Forest Baptist Source Type: news

Could imaging payments for Aduhelm patients bust Medicare?
Overlooking imaging costs related to the controversial Alzheimer's disease dru...Read more on AuntMinnie.comRelated Reading: CMS to limit coverage of new drugs for Alzheimer's disease MRI sheds light on effects of aducanumab Alzheimer's drug CMS to analyze coverage of monoclonal antibody Alzheimer's drug SNMMI pushes for coverage of PET tracers for Aduhelm use FDA approves Alzheimer's treatment under accelerated pathway (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 14, 2022 Category: Radiology Source Type: news

Condition over 2 million people have in UK shown to treble Alzheimer's protein in brain
HUMANITY is locked in a vicious battle with dementia and the fight is set to intensify in the coming decades as populations age. Research aims to shed light on the early risk factors in a bid to forestall brain decline. New research published today shows a condition affecting 2.3 million in the UK directly causes Alzheimer's - the most common cause of dementia. (Source: Daily Express - Health)
Source: Daily Express - Health - January 14, 2022 Category: Consumer Health News Source Type: news

Cleaner Air Could Mean Healthier Brains for Older Women
Title: Cleaner Air Could Mean Healthier Brains for Older WomenCategory: Health NewsCreated: 1/14/2022 12:00:00 AMLast Editorial Review: 1/14/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 14, 2022 Category: Geriatrics Source Type: news

Outrage, Praise for CMS' Proposed Aducanumab Payment Policy Outrage, Praise for CMS' Proposed Aducanumab Payment Policy
Reaction to the Centers for Medicare& Medicaid Services'proposed decision to restrict coverage of the controversial and expensive Alzheimer's disease drug aducanumab has been swift and polarized.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 14, 2022 Category: Neurology Tags: Psychiatry News Source Type: news

Update: Medicare Is Not Planning To Pay For Expensive New Alzheimer ’s Drug
Just a couple of days ago, I wrote a column about aducamumab (Aduhelm), a new Alzheimer ’s treatment from Biogen. Medicare just announced that they agree with me. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 13, 2022 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Biogen tumbles after Medicare lays out Aduhelm coverage plan
Shares of Biogen have tumbled a day after regulators slapped strict limitations on coverage the drugmaker’s new Alzheimer’s disease treatment (Source: ABC News: Health)
Source: ABC News: Health - January 12, 2022 Category: Consumer Health News Tags: Health Source Type: news

CMS to limit coverage of new drugs for Alzheimer's disease
The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed a nationa...Read more on AuntMinnie.comRelated Reading: MRI sheds light on effects of aducanumab Alzheimer's drug SNMMI pushes for coverage of PET tracers for Aduhelm use PET radiotracer tweaked for greater precision in AD detection FDA approves Alzheimer's treatment under accelerated pathway (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 12, 2022 Category: Radiology Source Type: news

Medicare Proposes Restricting Coverage Of Aduhelm To Alzheimer ’s Patients Who Enroll In Clinical Trials
On January 11, Medicare issued a draft memorandum that it will only pay for Aduhelm under the so-called coverage with evidence development (CED) pathway. On one hand, proponents say Medicare can learn whether the drug works in the context of a CED study. On the other, critics say CED impedes access. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 12, 2022 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

Tai chi training as a primary daily care plan for better balance ability in people with Parkinson's disease: an opinion and positioning article - Zhang T, Lv Z, Gao S.
Parkinson's disease (PD) is a common degenerative disease of the central nervous system. Clinically, its incidence is second only to Alzheimer's disease, which seriously harms the health of middle-aged and elderly people (1). Main clinical manifestations o... (Source: SafetyLit)
Source: SafetyLit - January 12, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Medicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical Trials
Title: Medicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical TrialsCategory: Health NewsCreated: 1/11/2022 12:00:00 AMLast Editorial Review: 1/12/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 12, 2022 Category: Geriatrics Source Type: news

Medicare Intends to Limit Payment for Controversial Alzheimer's Drug Medicare Intends to Limit Payment for Controversial Alzheimer's Drug
CMS seeks to limit pay for aducanumab and expected similar follow-on drugs to cases where people are enrolled in clinical trials.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 12, 2022 Category: Neurology Tags: Psychiatry News Alert Source Type: news

Medicare limits coverage of $28,000-a-year Alzheimer's drug
Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned (Source: ABC News: Health)
Source: ABC News: Health - January 12, 2022 Category: Consumer Health News Tags: Health Source Type: news

Medicare Proposes to Sharply Limit Coverage of the Alzheimer ’s Drug Aduhelm
If the preliminary decision is finalized this spring, it would restrict coverage to patients in randomized clinical trials. (Source: NYT Health)
Source: NYT Health - January 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Drugs (Pharmaceuticals) Aduhelm (Drug) Elderly Alzheimer ' s Disease Medicare Centers for Medicare and Medicaid Services Biogen Inc your-feed-healthcare Source Type: news

Medicare proposes covering expensive Alzheimer's drug for those in clinical trials
(Source: NPR Health and Science)
Source: NPR Health and Science - January 12, 2022 Category: Consumer Health News Authors: Jonathan Franklin Source Type: news

Medicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical Trials
TUESDAY, Jan. 11, 2022 -- It's a move that could severely limit the number of people taking the controversial new Alzheimer's drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 11, 2022 Category: General Medicine Source Type: news

Medicare Seeks To Limit Coverage For Controversial Alzheimer ’s Drug Aduhelm
Doctors demanded the FDA revoke its approval for the Alzheimer ’s drug Aduhelm, which can cause side effects like brain bleeding. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 11, 2022 Category: Pharmaceuticals Authors: Zachary Snowdon Smith, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news

Medicare Won ’t Pay For Controversial Alzheimer’s Drug Aduhelm Without A New Trial
In a key decision, the Centers for Medicare and Medicaid Services (CMS) said today that Medicare will not pay for the controversial Alzheimer ’s drug Adulhelm until it sees positive results from a government-approved trial. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 11, 2022 Category: Pharmaceuticals Authors: Howard Gleckman, Senior Contributor Tags: Personal Finance /personal-finance Money /money Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Breaking breaking-news investing personalfinance Source Type: news

Medicare proposes to cover controversial Alzheimer's drug with restrictions
Medicare has proposed covering the controversial and costly Alzheimer's drug Aduhelm only for those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced... #aduhelm #alzheimer (Source: Reuters: Health)
Source: Reuters: Health - January 11, 2022 Category: Consumer Health News Source Type: news

Medicare plans to cover Biogen drug only for patients in clinical trials
Medicare will only cover the cost of Aduhelm, the Alzheimer's drug made by Biogen Inc., for certain patients enrolled in clinical trials if the feds stick to a preliminary decision issued by the Centers for Medicare and Medicaid Services (CMS). The federal agency posted a proposed decision to its website on Tuesday afternoon. Biogen (Nasdaq: BIIB) shares began to slide in after-hours trading, dropping by about 6% in the first hour after the closing bell. The final CMS decision will not come until… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 11, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news

Medicare Will Not Fully Cover Aduhelm, the Controversial —and Costly—Alzheimer’s Disease Drug
Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned, a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices. The initial determination from the Centers for Medicare and Medicaid Services means that patients taking Biogen’s Aduhelm medication will have to be part of research efforts to assess the drug’s effectiveness in slowing the progression of dementia. Medicare’s national coverage determination would become final this spr...
Source: TIME: Science - January 11, 2022 Category: Science Authors: RICARDO ALONSO-ZALDIVAR / AP Tags: Uncategorized Drugs healthscienceclimate wire Source Type: news

Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums
(Source: ABC News: Health)
Source: ABC News: Health - January 11, 2022 Category: Consumer Health News Tags: Health Source Type: news

More Olive Oil May Bring Longer Life
People who consume more than 1/2 a tablespoon of olive oil a day are less likely to die from heart disease, cancer, neurodegenerative diseases like Alzheimer's or lung disease. (Source: WebMD Health)
Source: WebMD Health - January 11, 2022 Category: Consumer Health News Source Type: news

Scientists Work Out How Exercise Saves Your Brain
Title: Scientists Work Out How Exercise Saves Your BrainCategory: Health NewsCreated: 1/10/2022 12:00:00 AMLast Editorial Review: 1/11/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 11, 2022 Category: Geriatrics Source Type: news

Medicare May Rethink Premium Hike for Pricey Alzheimer ’s Drug
Title: Medicare May Rethink Premium Hike for Pricey Alzheimer ’s DrugCategory: Health NewsCreated: 1/10/2022 12:00:00 AMLast Editorial Review: 1/11/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 11, 2022 Category: Geriatrics Source Type: news

Medicare May Rethink Premium Hike for Pricey Alzheimer Drug
MONDAY, Jan. 10, 2022 -- Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer disease drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra's... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 10, 2022 Category: Pharmaceuticals Source Type: news

Medicare Told to Reassess Premium Hike for Alzheimer's Drug
The directive comes after drugmaker Biogen slashed the price of the medication. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - January 10, 2022 Category: American Health Source Type: news

Medicare May Rethink Premium Hike for Pricey Alzheimer ’s Drug
MONDAY, Jan. 10, 2022 -- Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer's drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra's directive,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 10, 2022 Category: General Medicine Source Type: news

Biogen defends Alzheimer's drug, highlights pipeline at J.P. Morgan conference
In a high-stakes presentation at the J.P. Morgan Healthcare conference, Biogen Inc. executives said they wanted to "improve the community's understanding" of Aduhelm but left less than 10 minutes to answer questions from investors and attendees. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 10, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Scientists Work Out How Exercise Saves Your Brain
MONDAY, Jan. 10, 2022 -- Exercise helps you stay fit, hale and hearty, and researchers say it may also help you stave off dementia and Alzheimer's disease. Now they have a better understanding of the hidden benefits that aid the brain. Older folks... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 10, 2022 Category: General Medicine Source Type: news

Medicare told to reassess premium hike for Alzheimer's drug
U.S. health secretary Xavier Becerra is ordering Medicare to reassess a big premium increase facing millions of seniors this year (Source: ABC News: Health)
Source: ABC News: Health - January 10, 2022 Category: Consumer Health News Tags: Health Source Type: news

4 Reasons Why The New Alzheimer ’s Treatment Is Bad News For Patients
More than a year ago, I wrote about the failure of two trials of a new Alzheimer ’s treatment, called aducamumab. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 10, 2022 Category: Pharmaceuticals Authors: Steven Salzberg, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Aduhelm: Will Medicare Cover the Controversial Alzheimer ’ s Drug?
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 7, 2022 Category: Psychiatry Tags: Family Medicine, Geriatrics, Neurology, Pharmacy, Psychiatry, News, Source Type: news

Aduhelm: Will Medicare Cover the Controversial Alzheimer's Drug?
FRIDAY, Jan. 7, 2022 -- Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer's drug Aduhelm. The drug's benefits are in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 7, 2022 Category: General Medicine Source Type: news

Aduhelm: Will Medicare Cover the Controversial Alzheimer's Drug?
Title: Aduhelm: Will Medicare Cover the Controversial Alzheimer's Drug?Category: Health NewsCreated: 1/7/2022 12:00:00 AMLast Editorial Review: 1/7/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 7, 2022 Category: Geriatrics Source Type: news

What MRI sequence is best for brain volumetry?
Although automated volumetry can be performed on an ultrafast 3D brain MRI sequence...Read more on AuntMinnie.comRelated Reading: Brain lesions on MRI linked to contact sports MRI sheds light on effects of aducanumab Alzheimer's drug MRI predicts 2-year cognitive status in early-onset Alzheimer's Interventional radiologists are raking in more consulting fees AI-based reconstruction speeds up quantitative volumetric MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 7, 2022 Category: Radiology Source Type: news

Unhealthy Heart May Be Bigger Threat to Women's Brains Than Men's
Title: Unhealthy Heart May Be Bigger Threat to Women's Brains Than Men'sCategory: Health NewsCreated: 1/6/2022 12:00:00 AMLast Editorial Review: 1/6/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 6, 2022 Category: Geriatrics Source Type: news

UofL researchers reveal how oral bacteria suppress protection against viral growth
 Bacteria that cause periodontal disease reduce oral defense and increase viral growth By Betty Coffman LOUISVILLE, Ky. – Researchers from the University of Louisville School of Dentistry and their colleagues have discovered details of how proteins produced by oral epithelial cells protect humans against viruses entering the body through the mouth. They also found that oral bacteria can suppress the activity of the se cells, increasing vulnerability to infection. A family of proteins known as interferon lambdas produced by epithelial cells in the mouth serve to protect humans from viral infection,...
Source: Dental Technology Blog - January 6, 2022 Category: Dentistry Source Type: news

As Covid Hits Nursing Homes' Finances, Town Residents Fight to Save Alzheimer's Facility
Reports on the closure of an Alzheimer's care facility in western Missouri due to financial hardship and the concerns of local residents about accessing long-term care for relatives and seniors in the area. Discusses the uncertain future of nursing homes nationwide in the face of COVID-19, noting that 54% reported financial losses and that 134 nursing homes closed in 2021. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 4, 2022 Category: Rural Health Source Type: news

The (other) surprising uses for Viagra
Could Viagra be a Swiss Army knife of drugs, helping to cure lethal diseases such as Covid, Alzheimer's and cancer, as well as bringing its more famous sexual benefit? (Source: the Mail online | Health)
Source: the Mail online | Health - January 4, 2022 Category: Consumer Health News Source Type: news

More U.S. Seniors, Especially Women, Are Retaining Healthy Brains: Study
Title: More U.S. Seniors, Especially Women, Are Retaining Healthy Brains: StudyCategory: Health NewsCreated: 12/30/2021 12:00:00 AMLast Editorial Review: 1/3/2022 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - January 3, 2022 Category: Geriatrics Source Type: news